According to reports, a Massachusetts company focused on integrated practice management and electronic health records has received federal approval to acquire Epocrates, a mobile app developer, for $293 million. Athenahealth won the clearance to buy the company that develops apps for clinical settings which allows users to directly access information in Athenahealth’s electronic health records. The US Federal Trade Commission announced their approval of the deal on Monday.
Full content: ModernHealthcare.com
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Turkey Ends Meta Investigation Over Threads and Instagram
Dec 8, 2024 by
CPI
Supreme Court to Hear CCI Petition on Amazon, Flipkart Antitrust Cases
Dec 8, 2024 by
CPI
Senators Urge Antitrust Probe Into FanDuel and DraftKings
Dec 8, 2024 by
CPI
Novo Holdings Secures EU Approval for $16.5 Billion Catalent Acquisition
Dec 8, 2024 by
CPI
US Appeals Court Upholds TikTok Divestment Law, Paving Way for Potential Ban
Dec 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI
Assessing the Potential for Antitrust Moats and Trenches in the Generative AI Industry
Nov 29, 2024 by
Allison Holt, Sushrut Jain & Ashley Zhou
How SEP Hold-up Can Lead to Entrenchment
Nov 29, 2024 by
Jay Jurata, Elena Kamenir & Christie Boyden
The Role of Moats in Unlocking Economic Growth
Nov 29, 2024 by
CPI
Overcoming Moats and Entrenchment: Disruptive Innovation in Generative AI May Be More Successful than Regulation
Nov 29, 2024 by
Simon Chisholm & Charlie Whitehead